N/A
Manufactured by Camber Pharmaceuticals, Inc.
35,207 FDA adverse event reports analyzed
Last updated: 2026-04-14
PRAMIPEXOLE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Camber Pharmaceuticals, Inc.. The most commonly reported adverse reactions for PRAMIPEXOLE include DRUG INEFFECTIVE, FALL, FATIGUE, NAUSEA, PAIN. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for PRAMIPEXOLE.
Out of 14,398 classified reports for PRAMIPEXOLE:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
This profile reflects 35,207 FDA FAERS reports that mention PRAMIPEXOLE. Reporting is voluntary and does not prove that the drug caused any listed event.
Frequently reported terms in FAERS include DRUG INEFFECTIVE, FALL, FATIGUE, NAUSEA, PAIN, CONDITION AGGRAVATED. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.
Labeling and FAERS entries often list Camber Pharmaceuticals, Inc. in connection with PRAMIPEXOLE. Always verify the specific product and NDC with your pharmacist.